Hacker Newsnew | past | comments | ask | show | jobs | submit | fromlogin
Would Walter White Still Cook Meth in 2025? (alexkesin.com)
2 points by quadrin 9 months ago | past | 1 comment
Fun with FGF21 (alexkesin.com)
1 point by quadrin 11 months ago | past
How Amgen Lost the PCSK9 Patent War (alexkesin.com)
17 points by quadrin 11 months ago | past | 1 comment
The Cowboy of Generic Drugs (alexkesin.com)
1 point by jdcampolargo on Sept 1, 2025 | past
The Cowboy of Generic Drugs (alexkesin.com)
10 points by quadrin on Aug 25, 2025 | past | 1 comment
The Day Novartis Chose Discovery (alexkesin.com)
1 point by irsagent on Aug 9, 2025 | past
The Day Novartis Chose Discovery (alexkesin.com)
29 points by quadrin on Aug 5, 2025 | past | 10 comments
The Hollow Men of Hims (alexkesin.com)
214 points by quadrin on June 25, 2025 | past | 266 comments
Biotech Life in the Software City (alexkesin.com)
1 point by quadrin on June 5, 2025 | past
[flagged] Against "Against Life Extension" (alexkesin.com)
27 points by quadrin on June 4, 2025 | past | 31 comments
Mr. Secretary, Reclassify the Statin (alexkesin.com)
20 points by paulpauper on May 17, 2025 | past | 14 comments
China's leap in pharma: slow and fast trends behind its rise (alexkesin.com)
5 points by quadrin on Feb 21, 2025 | past
How the new FDA can turbocharge drug development (alexkesin.com)
2 points by quadrin on Feb 14, 2025 | past
Narrow Leverage: How Small Strengths Create Big Power (alexkesin.com)
3 points by quadrin on Feb 14, 2025 | past
Etifoxine: Is this drug a Xanax killer? (alexkesin.com)
3 points by quadrin on Aug 14, 2023 | past
Etifoxine: Is this drug a Xanax killer? (alexkesin.com)
2 points by quadrin on Aug 13, 2023 | past
Do's and don'ts of valuing biotech companies (alexkesin.com)
1 point by quadrin on July 28, 2023 | past
Keeping Up with the Thiel Fellows (alexkesin.com)
2 points by quadrin on Feb 13, 2023 | past
Dr. Levin and Mr. Hyde (alexkesin.com)
1 point by quadrin on June 2, 2022 | past

Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: